This topic contains a solution. Click here to go to the answer

Author Question: The client is to receive Augmentin (amoxicillin/clavulanate potassium) 0.25 gram po every 8 hours. ... (Read 40 times)

pepyto

  • Hero Member
  • *****
  • Posts: 547
The client is to receive Augmentin (amoxicillin/clavulanate potassium) 0.25 gram po every 8 hours. The medication Augmentin (amoxicillin/clavulanate potassium) is available as an oral suspension 125 mg/5 mL.
 
  How many teaspoons should the nurse instruct the client to take?
  A) 1
  B) 2
  C) 3
  D) 4

Question 2

The client is to receive Tagamet (cimetidine) 300 mg po every 6 hours. The medication is available as Tagamet (cimetidine) 300 mg/5 mL. How many teaspoons should the nurse instruct the client to take?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bob

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

B

Answer to Question 2

1




pepyto

  • Member
  • Posts: 547
Reply 2 on: Jul 3, 2018
:D TYSM


LegendaryAnswers

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library